Apontis Pharma AG (FRA:APPH)
11.05
+0.20 (1.84%)
Last updated: May 13, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Single Pills - Hypertension | 25.64M |
Log In |
Log In |
Log In |
Log In |
Single Pills - Hypertension Growth | -29.84% |
Log In |
Log In |
Log In |
Log In |
Co-Marketing - CO PD (Respiratory Diseases) | 7.96M |
Log In |
Log In |
Log In |
Log In |
Co-Marketing - CO PD (Respiratory Diseases) Growth | -20.21% |
Log In |
Log In |
Log In |
Log In |
Corporate Brands (without Single Pills) - Other | 2.05M |
Log In |
Log In |
Log In |
Log In |
Corporate Brands (without Single Pills) - Other Growth | -3.07% |
Log In |
Log In |
Log In |
Log In |
Co-Marketing - Cardiovascular | 1.13M |
Log In |
Log In |
Log In |
Log In |
Co-Marketing - Diabetes | 175.00K |
Log In |
Log In |
Log In |
Log In |
Co-Marketing - Diabetes Growth | -97.44% |
Log In |
Log In |
Log In |
Log In |
Corporate Brands (without Single Pills) - Gynecology | - |
Log In |
Log In |
Log In |
Log In |
Corporate Brands (without Single Pills) - Gynecology Growth | - |
Log In |
Log In |
Log In |
Log In |
Corporate Brands (without Single Pills) - Vascular | - |
Log In |
Log In |
Log In |
Log In |
Corporate Brands (without Single Pills) - Vascular Growth | - |
Log In |
Log In |
Log In |
Log In |
Dafiro | - |
Log In |
Log In |
Log In |
Log In |
Dafiro Growth | - |
Log In |
Log In |
Log In |
Log In |
Corporate Brands (without Single Pills) - Arthritis | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Germany | 36.96M |
Log In |
Log In |
Log In |
Log In |
Germany Growth | -33.67% |
Log In |
Log In |
Log In |
Log In |